Ann: Trading Halt, page-33

I have few cancer discovery bio tecks that trading halt prior to releasing trial results.

We just have to be aware of buy the rumour sell the news when Wednesday comes around.

If results are compelling we should do ok. We have to remember that this is still a pre=clinical study. So still some development needed before its a long covid treatment. I will need to revisit the Emergency Use Application criteria, but think long covid mightn't qualify. And that from the top of my head, so check that to be sure.

Regardless, good news on this is a very positive thing indeed. ANP is very under valued when its pipeline and potential is considered. Lots of upside to share price available even now, as the msrket value is so low.